Journal: BMC Cancer
Article Title: Conjoining cell reprogramming and mass spectrometry to identify the proteomic variations in the reprogrammed bladder cancer cells: finding cues of normalisation
doi: 10.1186/s12885-026-15634-x
Figure Lengend Snippet: Behavioural assays with bladder cancer cells and reprogrammed bladder cancer cells. A Crystal violet staining of colonies of HTB-5 and HTB-5 PR. HTB-5 cells formed smaller and more colonies, while HTB-5 PR cells form fewer but larger colonies (± SD, n = 3, 2-tailed unpaired t-test, HTB-5 v HTB-5 PR, * P < 0.05) B Cell proliferation was assessed using the CCK-8 assay. HTB-5 and HTB-5 PR cells were treated with increasing doses of paclitaxel or with doxorubicin for 36 h. Paclitaxel inhibited the growth of both HTB-5 and HTB-5 PR cells in a dose-dependent manner (upper graph). Doxorubicin inhibited the growth of both HTB-5 and rep HTB-5 in a dose-dependent manner (lower graph). Data are presented as the means ± SD (error bars) from two independent experiments. (Mean ± SD, n = 3, 2-tailed unpaired t-test, HTB-5 v control; ** p < 0.05, * p < 0.01. HTB-5 PR vs. control; ## p < 0.05, # p < 0.01. CCK-8: Cell-Counting Kit-8; Pac: Paclitaxel, Dox: Doxorubicin; SD: standard deviation.) C A clonogenic assay was performed after exposing the cells to increasing doses of doxorubicin or paclitaxel. Colony forming ability was depicted as relative colony number at 560 nm (right). Mean ± SD, n = 3, 2-tailed unpaired t-test, HTB-5 v control; ** p < 0.05, * p < 0.01. HTB-5 PR vs. control; ## p < 0.05, # p < 0.01) D Effect of cancer cell reprogramming on transwell migration and invasion. The number of migrating HTB-5 PR cells was determined by quantifying the amount of crystal violet at an OD at 560 nm (± SD, n = 3, 2-tailed unpaired t-test, HTB-5 v HTB-5 PR, * p < 0.05) E Comparison of migration abilities by wound healing assay. HTB-5 and HTB-5 PR cells were treated with increasing doses of paclitaxel, and cell migration was observed at 24, 48 and 72 h. HTB-5 PR cells migrated to close the wound, while different doses of paclitaxel inhibited cell migration, increased cell death as observed in parental HTB-5 cells. The wound widths are depicted as bar graphs (lower panel)
Article Snippet: Human grade 4 bladder cancer cell line HTB-5 (ATCC TCCSUP, RRID: CVCL_1738) and immortalised uroepithelial cell line SV-HUC-1 (ATCC CRL-9520, RRID: CVCL_3798 ) were obtained from the American Type Culture Collection (ATCC, USA).
Techniques: Staining, CCK-8 Assay, Control, Cell Counting, Standard Deviation, Clonogenic Assay, Migration, Comparison, Wound Healing Assay